Page last updated: 2024-10-22

amifostine anhydrous and Hearing Loss, Sensorineural

amifostine anhydrous has been researched along with Hearing Loss, Sensorineural in 3 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Hearing Loss, Sensorineural: Hearing loss resulting from damage to the COCHLEA and the sensorineural elements which lie internally beyond the oval and round windows. These elements include the AUDITORY NERVE and its connections in the BRAINSTEM.

Research Excerpts

ExcerptRelevanceReference
"Ototoxicity is a common side effect of high-dose cisplatin treatment."1.32High-dose Cisplatin with amifostine: ototoxicity and pharmacokinetics. ( Ehrsson, H; Ekborn, A; Eksborg, S; Hansson, J; Laurell, G; Wagenius, G; Wallin, I, 2004)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ekborn, A1
Hansson, J1
Ehrsson, H1
Eksborg, S1
Wallin, I1
Wagenius, G1
Laurell, G1
Rubin, JS1
Wadler, S1
Beitler, JJ1
Haynes, H1
Rozenblit, A1
McGill, F1
Goldberg, G1
Runowicz, C1
Church, MW1
Kaltenbach, JA1
Blakley, BW1
Burgio, DL1

Trials

1 trial available for amifostine anhydrous and Hearing Loss, Sensorineural

ArticleYear
Audiological findings in a Phase I protocol investigating the effect of WR 2721, high-dose cisplatin and radiation therapy in patients with locally advanced cervical carcinoma.
    The Journal of laryngology and otology, 1995, Volume: 109, Issue:8

    Topics: Amifostine; Antineoplastic Agents; Audiometry; Cisplatin; Combined Modality Therapy; Drug Tolerance;

1995

Other Studies

2 other studies available for amifostine anhydrous and Hearing Loss, Sensorineural

ArticleYear
High-dose Cisplatin with amifostine: ototoxicity and pharmacokinetics.
    The Laryngoscope, 2004, Volume: 114, Issue:9

    Topics: Adult; Aged; Amifostine; Antineoplastic Agents; Audiometry, Pure-Tone; Auditory Threshold; Cisplatin

2004
The comparative effects of sodium thiosulfate, diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity.
    Hearing research, 1995, Volume: 86, Issue:1-2

    Topics: Amifostine; Animals; Anti-Bacterial Agents; Antidotes; Antineoplastic Agents; Auditory Threshold; Ci

1995